SCHEMBL23727414

SCHEMBL23727414

Cc1cs/c(=N/C(=O)O)n1CC1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
LMNA P02545 1/20 0.53
RAB9A P51151 4/20 0.44
HSD17B10 Q99714 1/20 0.44
NOTUM Q6P988 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 2/20 0.39
TP53 P04637 2/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HCRTR1 O43613 1/20 0.39
MAPK10 P53779 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
FEN1 P39748 2/20 0.39
CNR2 P34972 4/20 0.38
POLB P06746 2/20 0.38
TSHR P16473 1/20 0.38
RXFP1 Q9HBX9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23727415 1.00 ALDH1A1 (0.53) ALDH1A1LMNARAB9AHSD17B10NOTUM
SCHEMBL23749780 0.85 ALDH1A1 (0.49) ALDH1A1LMNARAB9AHSD17B10NOTUM
SCHEMBL23727115 0.76 MCL1 (0.38) ALDH1A1RAB9AHSD17B10NOTUMNPC1
SCHEMBL23727116 0.76 MCL1 (0.38) ALDH1A1RAB9AHSD17B10NOTUMNPC1
SCHEMBL25003107 0.73 ALDH1A1 (0.48) ALDH1A1LMNARAB9AHSD17B10MEN1
SCHEMBL23749948 0.72 ALDH1A1 (0.52) ALDH1A1LMNARAB9AHSD17B10MEN1
SCHEMBL23749779 0.72 ALDH1A1 (0.48) ALDH1A1LMNARAB9AHSD17B10NOTUM
SCHEMBL13989551 0.67 CNR2 (0.57) ALDH1A1RAB9AHSD17B10MEN1KMT2A
SCHEMBL14886757 0.66 NOTUM (0.85) NOTUMMEN1KMT2ATP53CNR2
SCHEMBL23728038 0.62 CYP1A2 (0.51) ALDH1A1LMNARAB9AHSD17B10NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230137893-A1 PYRROLO[2,3-b]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS THE ROCKEFELLER UNIVERSITY (US) 2023-05-04 US disclosed
EP-4100008-A1 PYRROLO [2,3-B]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS The Rockefeller University (US) 2022-12-14 EP disclosed
WO-2021158936-A1 PYRROLO [2,3-B]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS THE ROCKEFELLER UNIVERSITY (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230137893-A1 PYRROLO[2,3-b]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS LATS2, LATS1, YAP1 ALDH1A1 3775/4885LMNA 1731/4885RAB9A 2076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.